Indraprastha Medical Corporation Ltd

Indraprastha Medical Corporation Ltd Share Price Today: Live Updates & Key Insights

Get insights on Indraprastha Medical Corporation Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.

Indraprastha Medical Corporation Ltd Share Price Chart

Indraprastha Medical Corporation Ltd Fundamentals

Traded Volume: 2,04,383

Market Cap(Cr): 4,737

Avg Traded Price 520.63

1 Year return 24.25%

Upper Circuit 532.9

Lower Circuit 514

P/E TTM 27.00

P/B Ratio 19.00

Traded Value(Cr) 1056.15

EPS TTM 19.061

Book value 19.061

Dividend 1.00%

Indraprastha Medical Corporation Ltd Share Price Performance

Shows the percentage change in stock price over different time periods

This section highlights Indraprastha Medical Corporation Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Indraprastha Medical Corporation Ltd share price history, short-term movements, long-term trends, and overall investor sentiment

1W -5.51%

1M -8.93%

3M +10.70%

1Y +24.25%

YTD -2.03%

Indraprastha Medical Corporation Ltd Traded Volume Movement

Shows the trading volume over different time periods

This section highlights Indraprastha Medical Corporation Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment

Yesterday 1.97L

Day Before Yesterday 2.83L

1W Avg 2.77L

1M Avg 8.02L

3M Avg 7.20L

Indraprastha Medical Corporation Ltd Technical Details

Indraprastha Medical Corporation Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.

Support 1 510

Support 2 502

Support 3 491

Pivot Point : 521

Resistance 1 528

Resistance 2 540

Resistance 3 547

Indraprastha Medical Corporation Ltd Corporate Actions

Indraprastha Medical Corporation Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Indraprastha Medical Corporation Ltd’s capital allocation strategies.

All

Ex-Date 18-Sep-2025 Type D Description 4.50/share@45.00% Record Date 18-Sep-2025 Ratio 45.00

Ex-Date 13-Sep-2024 Type D Description 4.50/share@45.00% Record Date - Ratio 45.00

Ex-Date 15-Sep-2023 Type D Description 3.00/share@30.00% Record Date - Ratio 30.00

Ex-Date 15-Sep-2022 Type D Description 2.50/share@25.00% Record Date - Ratio 25.00

Ex-Date 12-Sep-2019 Type D Description 1.60/share@16.00% Record Date - Ratio 16.00

Ex-Date 12-Sep-2018 Type D Description 1.50/share@15.00% Record Date - Ratio 15.00

Ex-Date 14-Sep-2017 Type D Description 1.80/share@18.00% Record Date - Ratio 18.00

Ex-Date 18-Aug-2016 Type D Description 1.80/share@18.00% Record Date - Ratio 18.00

Ex-Date 16-Sep-2015 Type D Description 1.80/share@18.00% Record Date - Ratio 18.00

Ex-Date 18-Sep-2014 Type D Description 1.80/share@18.00% Record Date - Ratio 18.00

Ex-Date 19-Sep-2013 Type D Description 1.60/share@16.00% Record Date - Ratio 16.00

Ex-Date 06-Sep-2012 Type D Description 1.60/share@16.00% Record Date - Ratio 16.00

Ex-Date 05-Sep-2011 Type D Description 1.60/share@16.00% Record Date - Ratio 16.00

Ex-Date 30-Aug-2010 Type D Description 1.60/share@16.00% Record Date - Ratio 16.00

Ex-Date 27-Aug-2009 Type D Description 1.50/share@15.00% Record Date - Ratio 15.00

Ex-Date 28-Aug-2008 Type D Description 1.40/share@14.00% Record Date - Ratio 14.00

Ex-Date 07-Sep-2007 Type D Description 1.25/share@12.50% Record Date - Ratio 12.50

Dividends

Announcement Date 18-Sep-2025 Ex Dividend Date 18-Sep-2025 Dividend(%) 45

Announcement Date 13-Sep-2024 Ex Dividend Date 13-Sep-2024 Dividend(%) 45

Announcement Date 15-Sep-2023 Ex Dividend Date 15-Sep-2023 Dividend(%) 30

Announcement Date 15-Sep-2022 Ex Dividend Date 15-Sep-2022 Dividend(%) 25

Announcement Date 12-Sep-2019 Ex Dividend Date 12-Sep-2019 Dividend(%) 16

Announcement Date 12-Sep-2018 Ex Dividend Date 12-Sep-2018 Dividend(%) 15

Announcement Date 14-Sep-2017 Ex Dividend Date 14-Sep-2017 Dividend(%) 18

Announcement Date 18-Aug-2016 Ex Dividend Date 18-Aug-2016 Dividend(%) 18

Announcement Date 16-Sep-2015 Ex Dividend Date 16-Sep-2015 Dividend(%) 18

Announcement Date 18-Sep-2014 Ex Dividend Date 18-Sep-2014 Dividend(%) 18

Announcement Date 19-Sep-2013 Ex Dividend Date 19-Sep-2013 Dividend(%) 16

Announcement Date 06-Sep-2012 Ex Dividend Date 06-Sep-2012 Dividend(%) 16

Announcement Date 05-Sep-2011 Ex Dividend Date 05-Sep-2011 Dividend(%) 16

Announcement Date 30-Aug-2010 Ex Dividend Date 30-Aug-2010 Dividend(%) 16

Announcement Date 27-Aug-2009 Ex Dividend Date 27-Aug-2009 Dividend(%) 15

Announcement Date 28-Aug-2008 Ex Dividend Date 28-Aug-2008 Dividend(%) 14

Announcement Date 07-Sep-2007 Ex Dividend Date 07-Sep-2007 Dividend(%) 13

Bonus

No Bonus has been declared by INDRAMEDCO

Splits

No Split has been declared by INDRAMEDCO

Others

Rights No Rights has been declared by INDRAMEDCO

Indraprastha Medical Corporation Ltd Peer Comparison

Shows key financial metrics for the company and its peers

This section compares Indraprastha Medical Corporation Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Indraprastha Medical Corporation Ltd's relative performance and valuation against major competitors.

Stock Name Healthcare Global Enterprises Ltd ₹723.95 (-2.57%) M. Cap (Cr) 102.08 1 Yr Return (%) +54.53% P/E (TTM) 288.52 PB Ratio 11.82

Stock Name Jupiter Life Line Hospitals Ltd ₹1441.00 (-2.03%) M. Cap (Cr) 94.48 1 Yr Return (%) -6.56% P/E (TTM) 47.58 PB Ratio 7.51

Stock Name Yatharth Hospital & Trauma Care Services Ltd ₹758.70 (-1.67%) M. Cap (Cr) 73.10 1 Yr Return (%) +24.31% P/E (TTM) 47.94 PB Ratio 7.75

Stock Name Indraprastha Medical Corporation Ltd ₹516.75 (-2.64%) M. Cap (Cr) 47.37 1 Yr Return (%) +24.25% P/E (TTM) 27.11 PB Ratio 9.03

Stock Name Artemis Medicare Services Ltd ₹278.38 (-1.59%) M. Cap (Cr) 44.04 1 Yr Return (%) -13.06% P/E (TTM) 46.38 PB Ratio 5.54

Stock Name Dr Agarwals Eye Hospital Ltd ₹5170.00 (-1.35%) M. Cap (Cr) 24.99 1 Yr Return (%) +3.57% P/E (TTM) 38.79 PB Ratio 13.27

Stock Name Shalby Ltd ₹217.21 (-2.25%) M. Cap (Cr) 23.46 1 Yr Return (%) +0.69% P/E (TTM) 523.92 PB Ratio 2.33

Indraprastha Medical Corporation Ltd Cash Flow

Cash flow data provides a view of how money is generated and spent by Indraprastha Medical Corporation Ltd, across its operating activities, investing activities, and financing activities.

PARTICULARS Operating Activities Mar 2025 156.75 Mar 2024 200.15 Mar 2023 144.47 Mar 2022 71.29 Mar 2021 27.90

PARTICULARS Investing Activities Mar 2025 -110.99 Mar 2024 -158.43 Mar 2023 -107.91 Mar 2022 -51.10 Mar 2021 -20.16

PARTICULARS Financing Activities Mar 2025 -45.88 Mar 2024 -32.38 Mar 2023 -26.04 Mar 2022 -3.37 Mar 2021 -3.15

PARTICULARS Net Cash Flow Mar 2025 -0.12 Mar 2024 9.34 Mar 2023 10.52 Mar 2022 16.82 Mar 2021 4.59

Indraprastha Medical Corporation Ltd Shareholding Pattern

This shows the ownership breakdown of Indraprastha Medical Corporation Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.

Promoter 51.0%

Public 43.08%

Other Institutions 0.89%

FII 2.41%

Mutual Funds 2.62%

About Indraprastha Medical Corporation Ltd

Indraprastha Medical Corporation Limited was incorporated on 16th March, 1988. The main business of the Company is to enhance the quality of life of patients by providing comprehensive, high-quality hospital services on a cost-effective basis. The Company was formed as a joint venture between the Government of Delhi and the Apollo Hospitals Group to establish the Indraprastha Apollo Hospitals. The Hospital provides international standard medical care, offering a wide range of multi-specialty services. Key specialties with strong growth and revenue potential include transplants, cardiology, oncology, neurology, and orthopaedics. The company came out with the public issue of 2,29,18,300 equity shares of Rs 10 each for cash at par aggregating Rs 22,91,83,000. IMCL is setting up a multi-disciplinary super speciality teritary care referral hospital at New Delhi. The hospital was originally planned to be located within the Indira Gandhi indoor stadium complex, Mahatma Gandhi Marg, New Delhi. The Company's efforts culminated on 18 September 1983, when India's first corporate hospital, Apollo Hospitals in Madras, came into existence. In 1998-99, stroke unit to cater for strokes (Brain attack) with 4 beds has been established and a new OT complex consisting of 6 operation theatres has been commissioned. It has even set up a body mind medicine department based on ancient Eastern philosophy.During 1999-2000, the company signed a MOU with the Governments of Tanzania and Mauritius to treat patients from these countries sponsored by their Governments. It also has tie-ups with private air transport companies to transfer critical cases.A Puva UV therapy unit, for treatment of complex skin conditions, has been added in the dertamology department. The hospital has also installed an automated system in the microbiology unit for rapid cultures. A satellite clinic of the hospital, providing out door consultations and diagnostic facilities, was opened in Feb.'2001, in Delhi. This clinic also functions as a referral and sample collection centre for laboratory investigation.A high energy linear accelerator was installed with multileaf collimeter enabling selective radiation to the affected part sparing normal tissue. A four digit telephone number '1066' was introduced by the Hospital for Emergency Medical Services and this is the first of its kind in the country. Three more super specialites namely Joint replacement,Spinal disorders and vascular surgeries have been started in the Hospital. The HIS is nearing completion and will be fully operational in the fag end of this financial year.During October 2001 the Hospital opened the Satellite Clinic at Golf Link,New Delhi.The new 57-bed Apollo Hospital in Noida offering secondary and tertiary services became operational in 2006. A specialized Clinic for Chest Pain under the banner `Apollo Chest Pain Centre (ACPC)' was launched in three locations, Bansal Hospital in Friends Colony, Sehgal Nursing Home in Paschim Vihar and the Apollo Clinic in Vasant Kunj, New Delhi.During 2009-10, Indraprastha Apollo Hospitals introduced Endoscopic Ultra Sonology (EUS), a major advancement in diagnosing and treating gastrointestinal and pancreato-biliary diseases. The Multi Organ Transplant unit of the Hospital performed 268 organ transplants in the financial year 2009-10 (117 liver and 151 kidney transplants). Significant renovation and upgradation work was completed during the year, which should add to patient comfort and help achieve more operational efficiencies. Among others, a new orthopaedics operation theatre, a 5-bed ICU for critical cardiac care patients, a 12 bed Multi Organ Transplant Unit for Renal Transplant patients, a Mezzanine in the atrium for ICU patient attendants and international patient lounge were commissioned. 58 patient rooms and 3 OPDs were also renovated.A new Endoscopic Ultrasound Unit was commissioned in 2010-11. A Bone Marrow Transplant Unit, one of the highest end of medical services, was also created in the Hospital for intensive treatment and management of certain cancers like leukemia, lymphomas and also some non-cancerous diseases like thalessaemia. A multi organ transplant unit was added to the increasing organ transplant demands. Renovated four OPD wings and day care facility. An OP pharmacy, OPD billing counter, Insurance TPA help desk and ICU patient lobby have been setup for the comfort and ease of patients.The expansion project undertaken by the Hospital was completed in 2011. In addition, a Cosmetic Centre was set up to provide aesthetic medicine on an out-patient basis. Out of the additional beds, 50 beds were commissioned. As part of the ongoing upgradation and renovation programme, a number of departments and units such as Gynecology & Pediatric OPD, Sample collection; Chemotherapeutics Admixture Room; Telemedicine Room; Fetal Medicine; Nucleic Acid Testing (NAT) Laboratory and Staff Cafeteria were refurbished to increase patient comfort and enhance operational efficiency. In order to meet the pressing demand of Dialysis and increased number of renal transplants, seven additional beds were commissioned in the Dialysis unit taking the capacity to 28. A new Out Patient Wing (OPD 2C) - with 14 Consultation rooms was commissioned in place of 28 general ward beds, to accommodate the new Consultants.The Expansion Project undertaken by the main Hospital to add 127 additional Beds comprising of 74 single rooms, 33 general ward beds and 20 ICU beds, was completed. With the completion of the expansion project, the total bed strength of the Hospital has increased to 710 beds in 2012-13. The Apollo Institute of Robotic Surgery was launched in June, 2012 and has been performing a good number of robotic surgeries with the Da-Vinci Robotic Surgical System. The Hospital commissioned the Cosmetic Clinic in 2012.In 2013-14, the Apollo Obesity and Metabolic Surgery (Bariatric surgery) Centre was commissioned. The Apollo Institute of Robotic Surgery, which was instituted last year, performed 173 surgeries during the year. The Renal Transplant services were commenced in September, 2013 and resulting to this, a total of 18 transplants were conducted in the Noida hospital during the year. The Pain Clinic was started in January 2014 offering integrated and comprehensive Pain Management for all kinds of pain. Given the rising burden of Non-Communicable Diseases and Diabetes, the Sugar Clinic was also started to help patients in better management of Diabetes and prevention of associated complications. The hospital also expanded its Emergency department with 10 additional beds being added along with a complete renovation. The total strength of the unit stands at 20 beds. Also, the Urology, Nephrology and Dermatology OP areas underwent renovation. A large number of equipments were replaced or upgraded in various specialities including Oncology, Fetal Medicine, Cosmetics, Cardiology and Microbiology along with OT and other equipment at the main hospital and in Noida.Project Priceless, an Apollo wide initiative supported by inputs from Bain & Company, to improve overall patient experience and improve patient and physician advocacy for the Hospital, commenced in June, 2014. Plastic and Cosmetic Surgery: New Anti-aging procedures have been introduced such as Mid-face volumization; Skin lifting and tightening Ulthera procedure for face, upper neck, lower neck and arms; and Cool Sculpting for non-invasive localized fat reduction for body contouring. In addition, a multitude of new investigation services have been started including Chromosomal Genetic Study, Contrast Enhanced Ultrasonography, etc. Various new Diagnostic or Surgical processes have also been added in different specialties such as Clot Evacuation in Urology, Tracheal or Bronchial Stent placement in Respiratory medicine, FET PET MRI for better imaging of brain tumours, Molecular Imaging, Nuclear Medicine, etc.The Central Asia e-Network link was launched on 12th July 2015. The event featured a tele-consultation for a cardiac patient between doctors in Osh city in Southern Kyrgyzstan, in Bishkek and with Apollo Hospital and AIIMS. The Hospital completed a successful cadaver split liver transplant wherein both the parts of the liver were given to two adult recipients. This was the first split liver transplant in two adults reported in the city and the second in India.Indraprastha Apollo Hospitals started providing Geriatric Services starting December 2016. New technique of Molecular Micro Film Array (Biofire) for rapid detection of micro-organisms in cases of meningitis/ encephalitis, sepsis, respiratory infections and gastroenteritis were introduced in Molecular Microbiology. In 2018-19, the Hospital commissioned a new state-of-the-art Chemotherapy Unit with 30 beds.During 2021-22, the Bone Marrow Transplant (BMT) project Unit, created a dedicated wing for BMT unit with 8 single rooms, 3 general ward beds and 1 procedure room, which was commissioned in August 2021. Bronchoscopy and PFT lab were cohorted in one area to make it man-power optimal. A 25-bedded Dialysis Unit was created in the Lower Basement of the hospital to create a better patient experience. Orthopaedic operating theatre was moved from Ground Floor to the first floor so that all theatres are cohorted in one area. The Radiology Unit was renovated to improve patient experience.The financial year 2022-23 was a year of reset for both, the clinical services, and the infrastructure. The hospital introduced a slew of differentiated clinical programmes including Structural Heart Diseases, minimally invasive and Robotic Cardiac Surgeries, Leadless pacemakers, Cardiodiagnostics like Cardiac MRI and niche Gastroenterological procedures like Third space endoscopy. Multiple cases of Total Hip replacements and many cases of complicated congenital heart diseases were carried out successfully by our team of doctors. A 71-year-old-male, diagnosed as a case of localized adenocarcinoma prostate, underwent a successful nerve sparing robotic radical prostatectomy with amniotic nerve wrap with bilateral pelvic lymph node dissection. A 61-year-old female patient successfully underwent a transcatheter mitral valve replacement (TMVR). A 64-year-old male from Fiji underwent Robotic assisted total arterial triple vessel coronary artery bypass surgery. A 28-year-old young man from Oman was treated successfully for a deformity in his left knee using 3-D printing technology. A 21-year-old male underwent a successful Robot assisted Trans-Oral surgery to remove a large parapharyngeal space tumour (tumour in the deep tissues of the neck, nerves, lymph nodes, and parts of salivary gland). A total hip arthroplasty was successfully performed on a 50-year-old. The patient was suffering with an extremely rare condition of `Primary Synovial chondromatosis of the Hip'. Several new equipment were added to hospital's arsenal. The most significant investment was the ZAP-X Gyroscopic Radiosurgery system. To accommodate the increasing number of clinical services and to better patient experience, the hospital undertook a series of transformative infrastructural revamp projects including cohorting all operating theatres, creating a cohorted endoscopy suite, new dialysis suite, new international patient lounge and new Oncology OPD. A biomethanation plant was set up with a capacity of 1 Ton to enable in-house treatment of Food, Kitchen, and Biomass waste and convert the waste into Biogas and Organic Manure.In 2024, Company performed more than 30 robotic cardiac surgeries, with zero mortality and it is working towards making Aortic surgeries easily accessible for the affected segment. A 70-year-old Australian woman with possible recurrence of ovarian/fallopian tube cancer, initially treated in 2015, underwent a laparoscopic excision of the recurrent tumor and umbilical nodule followed by dendritic cell therapy (DCT). The first robotic hip replacement using the direct anterior approach (bikini incision hip replacement) was performed for the first time in North India. An ascending aorta and aortic arch replacement with frozen elephant trunk was performed in a 58-year-old Kenyan patient with an ascending aorta aneurysm with dilated aortic arch and ulcer in proximal descending aorta. All the arch branches were reimplanted onto the prosthetic graft. The part of the procedure was done on total circulatory arrest using a special hybrid graft Thoraflex. The first supine PCNL for renal stones is an evolutionary change in procedure and was performed for the first time in Apollo Delhi. A multidisciplinary team, including Physicists, Neurosurgeons, ENT specialists, and Oncologists, successfully treated over 30 patients with various conditions using Stereotactic Gyroscopic Radiosurgery (Zap-X) for the first time in South Asia, with ongoing active follow-up. Successful Reverse Shoulder Replacement for Neglected Proximal Humerus Fracture was a challenging case as there was severe osteoporosis with proximal humeral bone loss and atrophied shoulder girdle musculature.In FY 2025, first robotic left lateral donor hepatectomy was performed for a one-year-old child with biliary atresia, with his father as the donor. A 16-year-old boy from Egypt with dilated cardiomyopathy (DCMP) and end-stage heart failure was mplanted with a Heart Mate 3 LVAD and recovered well. A 31-year-old female from Kenya presented with occasional back pain and abdominal pain. She was diagnosed with Takayasu's arteritis thoracoabdominal aortic aneurysm (TAAA) and anti-nuclear antibodies (ANA) positive. A 46-year-old female was diagnosed with left eye Choroidal Melanoma after experiencing flashes of light and photopsia for two month. The Company performedGRS with ZAP-X on a patient with ocular melanoma, delivering a precise dose to the lesion under anesthetic sedation.

Chairman & Non Executive Dir.

Jasmine Shah

Registered office Sarita Vihar, Delhi-Mathura Road, New Delhi, New Delhi, 110076

FAX :91-11-26925858/26925801

Background

Incorporation Year 1988

Face Value ₹10.00

Market Lot 1

Indraprastha Medical Corporation Ltd Latest News

VIEW MORE NEWS

FAQs on Indraprastha Medical Corporation Ltd